Bcl-2 family proteins and leukemia

Neoplasma

Volumn 45, Issue 3, 1998, Pages 117-112

  Kusenda, J ^a  

^a INSTITUTE OF CHEMISTRY   (Slovakia)

Author keywords

Bcl 2 oncogene; Bcl 2 protein; Chemoresistance; Leukemia; Lymphoma

Indexed keywords

PROTEIN BCL 2;

GENE EXPRESSION REGULATION; GENE FUNCTION; HUMAN; LEUKEMIA; LEUKEMOGENESIS; NONHUMAN; ONCOGENE; PROGNOSIS; PROTEIN EXPRESSION; SHORT SURVEY;

EID: 0031842787     PISSN: 00282685     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (47)

1. CAMPOS, L., ROUAULT, J.P., SABIDO, O., ORIOL, P., ROUBI, N., VASSELON, C., ARCHIMBAUD, E., MAGAUD, J.P., GUYOTAT, D.: High expression of Bcl-2 protein in acute myeloid leukemia cells is associated with poor response to chemotherapy. Blood, 81, 1993, 3091-3096.
2. CAMPOS, L., SABIDO, O., ROUAULT, J.P., GOYOTAT, D.: Effects of Bcl-2 antisense oligonucleotides on in vitro proliferation and survival of normal marrow progenitors and leukemic cells. Blood, 84, 1994, 595-600.
3. CHANG, B.S., MINN, A.J., MUCHMORE, S.W., FESIK, S.W., THOMPSON, C.B.: Identification of a novel regulatory domain in Bcl-xL and Bcl-2. EMBO J., 16, 1997, 968-977.
4. COOPER, K., HAFFAJEE, Z.: Bcl-2 and p53 protein expression in follicular lymphoma. J. Pathol., 182, 1997, 307-310.
5. COUSTAN-SMITH, E., KITANAKA, A., PUI, C.H., MC NINCH, L., EVANS, W.E., RAIMONDI, S.C., BEHM, F.G., ARICO, M., CAMPANA, D.: Clinical relevance of Bcl-2 overexpression on childhood acute lymphoblastic leukemia. Blood, 87, 1996, 1140-1146.
6. DELIA, D., AIELLO, A., SOLIGO, D., FONTANELLA, E., MELANI, C., PEZZELLA, F., PIEROTTI, M.A., PORTA, G.D.: Bcl-2 proto-oncogene expression in normal and neoplastic human myeloid cells. Blood, 79, 1992, 1291-1298.
7. GOTTARDI, D., ALFARANO, A., DE LEO, A.M., STACCHINI, A., BERGUI, L., CALIGARIS-CAPPIO, F.: Defective apoptosis due to bcl-2 overexpression may explain why B-CLL cells accumulate in Go. Curr. Top. Microbiol. Immunol., 194, 1995, 307-312.
8. HACKER, G., VAUX, D.L.: A sticky business. Curr. Biol., 5, 1995, 622-624.
9. HANADA, M., DELIA, D., AIELLO, A., STADTMAUER, E., REED, J.C.: Bcl-2 gene hypomethylation and high-level expression in B-cell chronic lymphocytic leukemia. Blood, 82, 1993, 1820-1828.
10. HANDA, H., HEGDE, U.P., KOTELNIKOV, V.M., MUNDLE, S.D., DONG, L.M., BURKE, P., ROSE, S., GASKIN, F., RAZA, A., PREISLER, H.D.: Bcl-2 and c-myc expression cell cycle kinetics and apoptosis during the progression of CML from diagnosis to blastic phase. Leuk. Res., 21, 1997, 479-489.
11. HENGARTNER, M.O., HORVITZ, H.R.: C. elegans cell survival gene ced-9 encodes a functional homolog of the mammalian protooncogene bcl-2. Cell, 76, 1994, 665-676.
12. HILL, M.E., MAC LENNAN, K.A., CUNNINGHAM, D.C., VAUGHAM, H.B., BURKE, M., CLARKE, P., STEFANO, F.D., ANDERSON, L., VAUGHAM, H.G., MASON, D., SELBY, P., LINCH, D.C.: Prognostic significance of bcl-2 expression and bcl-2 major breakpoint region rearrangement in diffuse large cell non-Hodgkin's lymphoma: A British national lymphoma investigation study. Blood, 88, 1996, 1046-1051.
13. KITADA, S., TAKAYAMA, S., DE RIEL, K., TANAKA, S., REED, J.C.: Reversal of chemoresistance of lymphoma cells by antisensemediated reduction of bcl-2 gene expression. Antisense Res. Dev., 4, 1994, 71-79.
14. KLUCK, R.M., BOSSY-WETZEL, E., GREEN, D.R., NEWMEYER, D.D.: The release of cytochrome c from mitochondria: A primary site for Bcl-2 regulation of apoptosis. Science, 275, 1997, 1132-1136.
15. KRAJEWSKI, S., TANAKA, S., TAKAYAMA, S., SCHIBLER, M.J., FENTON, W., REED, J.C.: Investigations of the subcellular distribution of the bcl-2 oncoprotein: Residence in the nuclear envelope, endoplasmic reticulum, and outer mitochondrial membranes. Cancer Res., 53, 1993, 4701-4714.
16. 2+ fluxes. Proc. Natl. Acad. Sci. USA, 91, 1994, 6569-6573.
17. MIDDLETON, G., NUNEZ, G., DAVIES, A.M.: Bax promotes neuronal survival and antagonises the survival effects of neutrotropic factors. Development, 122, 1996, 695-701.
18. MINN, A.J., VALEZ, P., SCHENDEL, S.L., LIANG, H., MUCHMORE, S.W., FESIK, S.W., FILL, M., THOMPSON, C.B.: Bcl-xL forms an ion channel in synthetic lipid membranes. Nature, 385, 1997, 353-357.
19. MONNI, O., JOENSUU, H., FRANSSILA, K., KLEFSTROM, J., ALITALO, K., KNUTILA, S.: Bcl-2 overexpression associated with chromosomal amplification in diffuse large B-cell lymphoma. Blood, 90, 1997, 1168-1174.
20. MOREB, J.S., SCHWEDER, M.: Human A1, a Bcl-2-related gene, is induced in leukemic cells by cytokines as well as differentiating factors. Leukemia, 11, 1997, 998-1004.
21. NAGATA, S.: Apoptosis by death factor. Cell, 88, 1997, 355-365.
22. NAUMOVSKI, L., CLEARY, M.L.: The p53-binding protean 53BP2 also interacts with Bcl-2 and impedes cell cycle progression at G2/M. Mol. Cell. Biol., 16, 1996, 3884-3892.
23. OLTVAI, Z.N., MILLIMAN, C.L., KORSMEYER, S.J.: Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell, 74, 1993, 609-619.
24. PEPPER, C., HOY, T., BENTLEY, D.P.: Bcl-2/Bax ratios in chronic lymphocytic leukemia and their correlation with in vitro apoptosis and clinical resistance. Br. J. Cancer, 76, 1997, 935-938.
25. PETTERSSON, M., JERNBERG-WIKLUND, H., LARSON, L.G., SUNDSTROM, C., GIVOL, I., TSUJIMOTO, Y., NILSSON, K.: Expression of the bcl-2 gene in human multiple myeloma cell lines and normal plasma cells. Blood, 79, 1992, 495-502.
26. REED, J.C.: Bcl-2 and regulation of programmed cell death. J. Cell. Biol., 124, 1994, 1-6.
27. REED, J.C.: Bcl-2 family proteins: Regulators of chemoresistance in cancer. Toxicol. Lett., 82, 1995, 155-158.
28. REED, J.C.: Bcl-2: Prevention of apoptosis as a mechanism of drug resistance. Hematol. Oncol. Clin. North Am., 9, 1995, 451-474.
29. REED, J.C.: Double identity for proteins of the Bcl-2 family. Nature, 387, 1997, 773-776.
30. REED, J.C.: Promise and problems of Bcl-2 antisense therapy. J. Natl. Cancer Inst., 89, 1997, 988-990.
31. SCHENDEL, S.L., XIE, Z., MONTAL, M.O., MATSUYAMA, S., MONTAL, M., REED, J.C.: Channel formation by antiapoptotic protein Bcl-2. Proc. Natl. Acad. Sci. USA, 94, 1997, 5113-5118.
32. SHAHAM, S., HORVITZ, H.R.: An alternatively spliced C. elegans ced-4 RNA encodes a novel cell death inhibitor. Cell, 86, 1996, 201-208.
33. SHIBASAKI, F., KONDO, E., AKAGI, T., MC KEON, F.: Suppression of signaling through NF-AT by interactions between calcineurin and Bcl-2. Nature, 386, 1997, 728-731.
34. THOMAS, A., EL ROUBY, S., REED, J.C., KRAJEWSKI, S., SILBER, R., POTMESIL, M., NEWCOMB, E.W.: Drug-induced apoptosis in B-CLL: Relationship between p53 gene mutation and bcl-2/ bax proteins in drug resistance. Oncogene, 12, 1996, 1055-1062.
35. THOMPSON, C.B.: Apoptosis in the pathogenesis and treatment of disease. Science, 267, 1995, 1456-1462.
36. TSUJIMOTO, Y., CROCE, C.M.: Analysis of the structure, transcripts, and protein products of bcl-2, the gene involved in human follicular lymphoma. Proc. Natl. Acad. Sci. USA, 83, 1986, 5214-5218.
37. UCKUN, F.M., YANG, Z., SATHER, H., STEINHERZ, P., NACHMAN, J., BOSTROM, B., CROTTY, L., SARQUIS, M., EK, O., ZEREN, T., TUBERGEN, D., REAMAN, G., GAYON, P.: Cellular expression of antiapoptotic Bcl-2 oncoprotein in newly diagnosed childhood acute lymphoblastic leukemia: A children's cancer group study. Blood, 89, 1997, 3769-3777.
38. VAN DONGEN, J.J.M., WOLVERS-TETTERO, I.L.M.: Analysis of immunoglobulin and T cell receptor genes. Part II: Possibilities and limitations in the diagnosis and management of lymphoproliferative diseases and related disorders. Clin. Chim. Acta, 198, 1991, 93-99.
39. VAUX, D.L.: CED-4 - The third horseman of apoptosis. Cell, 90, 1997, 389-390.
40. WANG, H.G., RAPP, U.R., REED, J.C.: Bcl-2 targets the protein kinase Raf-1 to mitochondria. Cell, 87, 1996, 629-638.
41. WEBB, A., CUNNINGHAM, D., COTTER, F., CLARKE, P.A., DI STEFANO, F., ROSS, P., CORBO, M., DZIEWANOWSKA, Z.: Bcl-2 antisense therapy in patients with non-Hodgkin lymphoma. Lancet, 349, 1997, 1137-1141.
42. XIANG, J., CHAO, D.T., KORSMEYER, S.J.: BAX-induced cell death may not require interleukin 1-converting enzyme-like proteases. Proc. Natl. Acad. Sci. USA, 93, 1996, 14 559-14 563.
43. YANG, E., KORSMEYER, S.J.: Molecular thanatopsis: A discourse on the Bcl-2 family and cell death. Blood, 88, 1996, 386-401.
44. YANG, J., LIU, X.S., BHALLA, K., KIM, C.N., IBRADO, A.M., CAI, J.Y., PERG, T.I., JONES, D.P., WANG, X.D.: Prevention of apoptosis by Bcl-2: Release of cytochrome c from mitochondria blocked. Science, 275, 1997, 1129-1132.
45. YANG, E., ZHA, J., JOCKEL, J., BOISE, L.H., THOMPSON, C.B., KORSMEYER, S.J.: Bad, a heterodimeric partner for Bcl-xL and Bcl-2, displaces Bax and promotes cell death. Cell, 80, 1995, 285-291.
46. ZIEGLER, A., LUEDKE, G.H., FABBRO, D., ALTMANN, K.H., STAHEL, R.A., ZANGEMEISTER-WITTKE, U.: Induction of apoptosis in small-cell lung cancer cells by an antisense oligonucleotide targeting the Bcl-2 coding sequence. J. Natl. Cancer Inst., 89, 1997, 1027-1036.
47. ZORATTI, M., SZABO, I.: Electrophysiology of the inner mitochondrial membrane. J. Bioenerg. Biomembr., 26, 1996, 543-553.